Bioanalytical and materials chemist. Twenty-five peer-reviewed journal articles, one IEEE conference paper and one book chapter — spanning DNA aptamer discovery by SELEX, aptamer-functionalized nanomaterials, and the translation of molecular recognition into biosensing and drug-delivery platforms.
Awarded for “Near-Field Millimetre-Wave Radar Sensing of a Slot-Loaded Dielectric Resonator.” Designed and synthesized the stimulus-responsive hydrogel — the sole functional sensing material at the core of the system.
Output by publication year across the current selection. Click a bar to isolate that year.
When the citations landed, not when the papers came out. Year breakdown live from OpenAlex, whose totals run slightly below Google Scholar's.
† equal contribution · * corresponding author. Citation counts are fetched live by DOI and will read lower than Google Scholar, which also counts preprints, theses and non-indexed venues. Journal-level metrics (impact factor, CAS tier) are available behind the “Journal metrics” switch above; they describe the journal, not the paper.
Ran capture-SELEX campaigns against five small-molecule targets — tobramycin, carbendazim, acetamiprid, cellulose and BPA — delivering high-affinity DNA aptamers and label-free light-up fluorescent (ThT) biosensors for therapeutic drug monitoring, food safety and environmental analysis. Resolved binding thermodynamics and structure by ITC, NMR and CD spectroscopy.
Built spherical nucleic acids by conjugating cornea-binding aptamers to gold nanoparticles through a thermal-evaporation route. Benchmarked six aptamer–AuNP conjugates for corneal tissue binding, HCEC cell targeting (Kd = 169 nM for Cornea-S5) and selective staining of corneal scars.
Partnered with the Electrical & Computer Engineering group (Prof. George Shaker) to transduce the biochemical state of stimulus-responsive hydrogels into millimetre-wave radar signatures, enabling non-contact, electronics-free biosensing.
Co-first-authored a comprehensive review of the biomedical applications of nanozymes from an enzymology perspective; contributed to aptamer-based Tl⁺ detection and to nuclease-resistant nanoflare studies.
Designed Ag/AgCl, Ag/AgBr and Au/Ag/AgI plasmonic photocatalysts for photodynamic therapy, developed carrier-free drug-delivery platforms, and synthesized biocompatible nanoparticles with antibacterial and anticancer activity.
Characterized the interactions of Au, CuS and Fe₃O₄ nanoparticles with liposomes and polymersomes; developed molecularly imprinted nanozymes with strongly enhanced substrate specificity; contributed to a liposome-based drug-delivery collaboration for cancer therapy with Grand River Hospital.
Full CV, reprints and unpublished data available on request.
[email protected]